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Abstract
Cytokines are small signaling proteins which play a key 
role in the human immune response. Chemotactic 
t ki ( h ki ) i d th di t d i ti f
 ,  
Synthesis
Peptoids are synthesized using the submonomer-method.3 In order to 
bind the chemokine N-terminus the peptoid side chains must 
complement the charges of the ELR-motif giving rise to the following 
Fluorescence-based binding assays
cy o nes c emo nes  n uce e rec e  m gra on o  
leukocytes. For several CXC-class chemokines, like 
Interleukin-8, the N-terminal “ELR”-motif is essential for 
receptor activation.1,2 In the course of this work 
pentameric peptoids are synthesized which bind to the 
ELR-motif due to ionic interactions thereby preventing 
lead-structure for the peptoids:
non-polar – basic – non-polar – acidic – non-polar
The resin-bound peptoids are incubated with a fluorescent model-
peptide which represents the N-terminus of Interleukin-8.
The fluorescence of individual beads is
HO
the binding of the chemokine to its receptor. The binding 
of the peptoids to the protein is tested by incubating the 
resin-bound peptoid with the fluorescently labelled N-
terminal sequence of a chemokine. The fluorescence of 
each bead can be quantified using a microarray 
scanner The hits are analyzed by mass spectrometry
HMBA-AM resin is used so that the side-chains can be deprotected 
without cleaving the peptoids from the resin
The structure of Interleukin-8, 
a chemokine of the CXC family
The ELR-motif at the N-terminus 
of CXC-chemokines
      
determined using a microarray scanner. The 
beads are transferred onto adhesive film and 
placed on glass slides. The fluorescence is 
measured at 532 nm.
1 2
3 4
1: resin without peptoid, 2, 3: peptoids without binding ability
4: peptoid (B7) with bound model-peptide (screening positive/hit)
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Summary and Outlook
• The identification of peptoids via mass spectrometry is possible.
• A first potential ligand was detected (peptoid B7) and the average 
bead-fluorescence was quantified with a microarray scanner.
MALDI MS/MS fragmentation patterns
Peptoids that vary in sequence but not in their overall mass can be 
positively identified based on their Y- and B-fragments.
Peptoid Analysis via Mass Spectrometry
A small library of pentameric peptoids has been synthesized to 
determine the applicability of mass spectrometry for the distinct 
identification of peptoids.
• In the future various new submonomers will be used to create a 
greater diversity for screening assays.
• Larger peptoid libraries will be synthesized using the mix-and-split 
method. Hits from the peptide binding assay will be identified by 
MS/MS.
• Hits will be synthesized in larger scale for binding assays with full 
l th h ki d i ti ith l k t
The Y- and B-series ions are typical for the peptoid fragmentation in 
MS/MS spectra.4
Peptoid B6






































eng  c emo nes an  m gra on assays w  eu ocy es.
• The peptoid sequence will be increased to decamers to enhance the 
specificity of binding to different cytokines.
Four amines of the pentameric sequence were gradually replaced by 
glycine to test if the residues have any effect on the expected Y- and 
B fragmentation
Peptoid B7
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Resin was treated with TFA prior to 
binding assays.
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